Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Nicotine Addiction from JUUL Pods Caused Life-Long Injury, Lawsuit Alleges November 26, 2019 Irvin Jackson Add Your Comments The manufacturers of JUUL pods lied about the nicotine addiction risks, according to allegations raised in a product liability lawsuit filed by a now-20 year old, who began vaping as a teen, before the company added any nicotine content warnings to JUUL. The complaint (PDF) was filed by Cody Bishop in the U.S. District Court for the Northern District of Ohio on November 21, indicating that the manufacturers sold JUUL pods for years without warning that vaping marketedly increased the risk of nicotine addiction in adolescents. Bishop was born on November 22, 2019, and indicates that he began vaping with JUUL Pods in 2007. As a result of the failure to warn about the risks associated with JUUL, Bishop indicates that he has a life-long injury since he is now permanently addicted to nicotine. LEARN MORE ABOUT VAPE PEN AND E-CIG LAWSUITS Serious lung injuries, respiratory illnesses, and nicotine addiction have been linked to a wide range of vaping products, including e-cigarettes and THC vape pens. Lawsuits are being pursued against manufacturers for failing to warn users about these risks. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About VAPE PEN AND E-CIG LAWSUITS Serious lung injuries, respiratory illnesses, and nicotine addiction have been linked to a wide range of vaping products, including e-cigarettes and THC vape pens. Lawsuits are being pursued against manufacturers for failing to warn users about these risks. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The lawsuit presents claims against JUUL Labs, Inc. and Pax Labs, Inc., indicating the manufacturers ignored the association between JUUL and nicotine addiction, and continued to market their products towards teens and prior non-smokers. The first warnings about nicotine addiction JUUL were not added to the product until August 2018. “When warning of safety and risks of JUUL, Defendants negligently and/or fraudulently represented to Plaintiff and the public in general, that JUUL did not create a high risk of nicotine addiction in adolescents,” the lawsuit states. “Defendants intentionally targeted adolescents in their marketing campaigns and through the production of flavored JUUL Pods that concealed the nicotine content contained in the JUUL Pods.” The complaint is one of a growing number of JUUL lawsuits being pursued nationwide by individuals, who often started vaping as minors, and now indicate they have become addicted to JUULing. Earlier this month, a study published in JAMA Network Open found that JUUL products deliver much higher amounts of nicotine to the blood than other e-cigarette products, increasing the risk of addiction. Recent FDA data indicates that teen e-cigarette use has reached epidemic levels in the United States, and JUUL Labs has been accused of fueling the growing teen nicotine addiction problems in the United States, through the design and marketing of their vape pen. JUUL was intentionally designed in a way that allowed teens to hide their vaping habit from parents, teachers and other adults. It was also sold in various candy-like flavors, which has resulted in a large number of teens and prior non-smokers starting to vape. Another recent study indicated e-cigarette advertising reaches 80% of middle and high school students in the U.S. Another study warns that vaping during adolescence quadruples a teen’s risk of becoming a cigarette tobacco smoker later. On September 9, the FDA issued a warning letter to JUUL, indicating there was evidence it told school-aged children that its products were safer than cigarettes, which has not been proven. Later that month the CEO stepped down after it was announced JUUL was the target of a criminal investigation, and the company ceased all advertising in the U.S. Last month, the company ceased marketing of its non-traditional flavored products, except tobacco, menthol and mint. As more parents and young adults step forward to pursue claims after becoming addicted to JUUL, it is widely expected that thousands of cases will be presented throughout the federal court system. In October, the U.S. Judicial Panel on Multidistrict Litigation issued an order consolidating all JUUL cases pending throughout the federal court system before Judge William H. Orrick III, in the U.S. District Court for the Northern District of California, which is where JUUL Labs, Inc.’s San Francisco headquarters are located. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Children, Drug Addiction, E-Cigarette, Electronic Cigarette, Juul, Nicotine, Vaping More JUUL E-Cigarette Vape Lawsuit Stories More Than Half of U.S. Teens Who Vape Do So To Deal With Stress, Anxiety: Study November 18, 2024 On-Line Retailers Receive FDA Warning Letter Over Illegal Sale of Disposable E-Cigarettes May 7, 2024 Vaping Causes Same DNA Damage as Smoking, Study Finds April 12, 2024 0 Comments EmailThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Sudden Ozempic Blindness Reports Raise Concerns Over NAION Side Effects (Posted: 2 days ago) An increasing number of Ozempic and Mounjaro users are reporting sudden, irreversible vision loss from NAION side effects, prompting new lawsuits and a federal push to consolidate blindness claims into a dedicated multidistrict litigation. MORE ABOUT: OZEMPIC LAWSUITOzempic, Similar Drugs Linked to Higher Risk of GI Side Effects: Study (11/21/2025)Lawsuits Over Ozempic Vision Loss and Gastrointestinal Injuries Will Be Separately Managed in NJ State Court (11/17/2025)Judge Extends Deadlines To Address GLP-1 Lawsuit ‘Cross-Cutting’ Issues (10/28/2025) Ongoing Cartiva Lawsuit Settlement Negotiations Cited as Reason to Reject MDL Consolidation (Posted: 3 days ago) Cartiva is urging federal judges to reject consolidation of toe-implant lawsuits, arguing that an MDL would interfere with individual claim resolutions that the company says are already being handled efficiently outside of court. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Lawsuits Allege Toe Implant Fails in About 64% of Patients (11/12/2025)MDL Sought for Cartiva Implant Lawsuits Filed in Federal Court System (11/03/2025)Lawsuit Claims Cartiva SCI Failure Caused by Defective Design of Big Toe Implant (09/18/2025) Covidien Symbotex Mesh Lawsuit Reset For Trial in July 2026 (Posted: 4 days ago) The first Covidien Symbotex mesh bellwether has been restored to the 2026 trial calendar, signaling renewed momentum in a litigation where more than 2,000 similar claims are still awaiting resolution. MORE ABOUT: HERNIA MESH LAWSUITFeb. 2026 Trial for Covidien Hernia Mesh Lawsuit Canceled by MDL Judge (11/05/2025)Covidien Seeks Dismissal of Lawsuits Over Hernia Mesh Complications (09/08/2025)Deadline for Covidien Mesh Settlement Negotiations Extended Until Jan. 2026 (08/21/2025)
On-Line Retailers Receive FDA Warning Letter Over Illegal Sale of Disposable E-Cigarettes May 7, 2024
Sudden Ozempic Blindness Reports Raise Concerns Over NAION Side Effects (Posted: 2 days ago) An increasing number of Ozempic and Mounjaro users are reporting sudden, irreversible vision loss from NAION side effects, prompting new lawsuits and a federal push to consolidate blindness claims into a dedicated multidistrict litigation. MORE ABOUT: OZEMPIC LAWSUITOzempic, Similar Drugs Linked to Higher Risk of GI Side Effects: Study (11/21/2025)Lawsuits Over Ozempic Vision Loss and Gastrointestinal Injuries Will Be Separately Managed in NJ State Court (11/17/2025)Judge Extends Deadlines To Address GLP-1 Lawsuit ‘Cross-Cutting’ Issues (10/28/2025)
Ongoing Cartiva Lawsuit Settlement Negotiations Cited as Reason to Reject MDL Consolidation (Posted: 3 days ago) Cartiva is urging federal judges to reject consolidation of toe-implant lawsuits, arguing that an MDL would interfere with individual claim resolutions that the company says are already being handled efficiently outside of court. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Lawsuits Allege Toe Implant Fails in About 64% of Patients (11/12/2025)MDL Sought for Cartiva Implant Lawsuits Filed in Federal Court System (11/03/2025)Lawsuit Claims Cartiva SCI Failure Caused by Defective Design of Big Toe Implant (09/18/2025)
Covidien Symbotex Mesh Lawsuit Reset For Trial in July 2026 (Posted: 4 days ago) The first Covidien Symbotex mesh bellwether has been restored to the 2026 trial calendar, signaling renewed momentum in a litigation where more than 2,000 similar claims are still awaiting resolution. MORE ABOUT: HERNIA MESH LAWSUITFeb. 2026 Trial for Covidien Hernia Mesh Lawsuit Canceled by MDL Judge (11/05/2025)Covidien Seeks Dismissal of Lawsuits Over Hernia Mesh Complications (09/08/2025)Deadline for Covidien Mesh Settlement Negotiations Extended Until Jan. 2026 (08/21/2025)